“The 40-Gene Expression Profile Test Identifies Patients with National Comprehensive Cancer Network High-Risk Cutaneous Squamous Cell Carcinoma at High Risk of Poor Outcomes to Inform Management Decisions”, J of Skin, vol. 9, no. 4, pp. 2426–2443, Jul. 2025, doi: 10.25251/mvr2rn83.